Novavax AB
556549-4019ActiveInnovating vaccines using proprietary technology platform and strategic partnerships.
Vaccine Developer / Biotechnology Companynovavax.com
Yleiskatsaus
- 100–199
- Työntekijät
- 500–1000milj SEK
- Liikevaihto
- 1997
- Perustettu
Avainpäättäjät
Rick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Novavax is a company dedicated to developing life-saving vaccine innovations to prevent serious illness and eradicate disease globally. They leverage a proprietary, cutting-edge technology platform featuring recombinant protein-based nanoparticles and their specialized Matrix-M® adjuvant. This platf...
VALNEVA SWEDEN AB